相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine
Raffaella Molteni et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus
Amelie Soumier et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Communication Between the Synapse and the Nucleus in Neuronal Development, Plasticity, and Disease
Sonia Cohen et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2008)
Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm
Silvia Begliuomini et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells
Marta Imbesi et al.
NEUROSCIENCE LETTERS (2008)
Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
Seithikurippu R. Pandi-Perumal et al.
PROGRESS IN NEUROBIOLOGY (2008)
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
Anne Dekeyne et al.
PSYCHOPHARMACOLOGY (2008)
New insights into BDNF function in depression and anxiety
Keri Martinowich et al.
NATURE NEUROSCIENCE (2007)
Mouse and rat BDNF gene structure and expression revisited
Tamara Aid et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model
Valerie Bertaina-Anglade et al.
BEHAVIOURAL PHARMACOLOGY (2006)
A neurotrophic model for stress-related mood disorders
Ronald S. Duman et al.
BIOLOGICAL PSYCHIATRY (2006)
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Mounira Banasr et al.
BIOLOGICAL PSYCHIATRY (2006)
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
SH Kennedy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states:: Focus on novel therapeutic strategies
MJ Millan
THERAPIE (2005)
BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
CR Bramham et al.
PROGRESS IN NEUROBIOLOGY (2005)
Contributions of 5-HT2C receptors to multiple actions of central serotonin systems
M Giorgetti et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways
MJ Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
New selective ligands of human cloned melatonin MT1 and MT2 receptors
V Audinot et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
Effect of agomelatine in the chronic mild stress model of depression in the rat
M Papp et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Role of melatonin in the regulation of human circadian rhythms and sleep
C Cajochen et al.
JOURNAL OF NEUROENDOCRINOLOGY (2003)
Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia
R Molteni et al.
MOLECULAR PSYCHIATRY (2001)
分享论文
